[The prostate cancer in the community of Madrid in 2000 I.- Incidence].

[The prostate cancer in the community of Madrid in 2000 I.- Incidence].
复制标题

DOI:
--
复制
发表时间:
2003
影响因子:
1.1
通讯作者:
F. Herranz Amo;F. Arias Fúnez;M. Arrizabalaga Moreno;F. J. Calahorra Fernández;J. C. Carballido Rodríguez;R. Diz Rodríguez;J. A. Herrero Payo;C. Llorente Abarca;J. M. Martín Martínez;L. Martínez-Piñeiro Lorenzo;R. Mínguez Martínez;J. Moreno Sierra;A. Rodríguez Antolín;J. T. Tamayo Ruíz;J. Turo Antona
F. Herranz Amo;F. Arias Fúnez;M. Arrizabalaga Moreno;F. J. Calahorra Fernández;J. C. Carballido Rodríguez;R. Diz Rodríguez;J. A. Herrero Payo;C. Llorente Abarca;J. M. Martín Martínez;L. Martínez-Piñeiro Lorenzo;R. Mínguez Martínez;J. Moreno Sierra;A. Rodríguez Antolín;J. T. Tamayo Ruíz;J. Turo Antona
中科院分区:
医学4区
文献类型:
--
作者:
F. Herranz Amo;F. Arias Fúnez;M. Arrizabalaga Moreno;F. J. Calahorra Fernández;J. C. Carballido Rodríguez;R. Diz Rodríguez;J. A. Herrero Payo;C. Llorente Abarca;J. M. Martín Martínez;L. Martínez-Piñeiro Lorenzo;R. Mínguez Martínez;J. Moreno Sierra;A. Rodríguez Antolín;J. T. Tamayo Ruíz;J. Turo Antona

文献摘要

被引文献

相似文献

目的了解2000年马德里自治区前列腺癌的发病率及其按卫生区的分类。材料与方法研究组织学证实的前列腺癌病例报告和回顾性数据采集2000年在马德里自治区,无论是从公共和私人医疗保健医院。结果:马德里自治区前列腺癌的总发病率为每10万男性100.4例。根据西班牙、欧洲和全球人群调整的发生率分别为120.1、103.5和68.6例/100,000男性。诊断时的平均年龄为70 ± 7.8(40-94)岁,中位数为70岁。70 ~ 79岁年龄组发病率较高。结论:马德里自治区前列腺癌的发病率低于美国,但高于欧盟大多数国家或地区。在自治区卫生区使用PSA检测的不同方式可以解释各地区发病率的差异。
OBJECTIVE To know the incidence in the year 2000 of prostate cancer in the Autonomous Community of Madrid and its breakdown by Health Areas. MATERIAL AND METHOD Study of histologically confirmed prostate cancer case reports and retrospective data acquisition for 2000 in the Autonomous Community of Madrid, both from Public and Private Health Care hospitals. RESULTS Gross incidence of prostate cancer in the Autonomous Community of Madrid was 100.4 cases per 100,000 males. The incidence adjusted for the Spanish, European and Worldwide population was 120.1, 103.5 and 68.6 cases per 100,000 males, respectively. Mean age at diagnosis was 70 +/- 7.8 (40-94) years, median of 70 years. The age group with higher incidence was 70 to 79 years. CONCLUSIONS The incidence of prostate cancer in the Autonomous Community of Madrid is lower than that in the US but higher than in most countries or regions in the EU. The different way of using PSA testing in the Health Areas of the Autonomous Community may explain the differences seen in terms of incidence by Area.